Morgan E. Meissner

Researchers characterized COVID-19 in patients with systemic lupus erythematosus and analyzed the association between comorbidities and medications and infection outcomes.

Researchers used machine-learning approaches to characterize the immune cell profile of patients with juvenile-onset SLE.

A set of 4 phenotypes for knee osteoarthritis with distinct pain trajectories which may be used to personalize treatment strategies were identified.

Researchers evaluated the adrenocorticotropic hormone as an alternative therapeutic option for acute gout, and its potential mechanisms of action.

Researchers developed a molecular test that predicts inadequate response to anti-TNF therapies in biologic-naive patients with rheumatoid arthritis.

Researchers evaluated the safety and efficacy of teriparatide for the treatment of severe osteoporosis in patients with Duchenne muscular dystrophy.

In this systematic review, the study authors evaluated the current evidence on orthogeriatric care for older patients with hip fracture.

Researchers assessed the effect of treatment with glucocorticoids and tocilizumab in patients with severe COVID-19-associated cytokine storm syndrome.

Researchers assessed the association between dysregulated central pain processing and treatment response in rheumatoid arthritis.

Researchers determined the prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome.

Researchers evaluated the racial differences in the clinical features, medication usage, and comorbidities of patients with AS in the US.

Researchers assessed and compared the fracture risk and prevalence of osteoporosis in patients with idiopathic inflammatory myopathy and rheumatoid arthritis.

This is the first study to describe the safety of IL-6 blockade with intravenous sarilumab in patients with COVID-19 pneumonia with systemic hyperinflammation.

Authors of a report presented the case of systemic sclerosis-polymyositis overlap syndrome in an adolescent with anti-Ku antibodies.

Researchers assessed whether arthritis autoantibodies can predict clinically suspect arthralgia in ACPA-positive patients without rheumatoid arthritis.

Researchers evaluated the risk for COVID-19 infection and its severity in patients receiving DMARDs.

Researchers assessed the effect of clinical enthesitis in patients with psoriatic arthritis.

Researchers assessed the reliability of a novel score to identify the characteristic lesions of dactylitis in psoriatic arthritis.

Researchers assessed the impact of primary hand osteoarthritis on bone mass, microstructure, and biomechanics in the affected skeletal regions.

Researchers identified criteria and non-criteria features associated with SLE, which can be used in classification criteria.

Researchers identified an association between distinct trajectories of pain and physical function and knee and hip osteoarthritis.

Researchers assessed the effectiveness of steroid injections vs systemic treatment on dactylitis in patients with psoriatic arthritis.

The ACE and AACE released a 2020 update to their clinical practice guidelines for the treatment and diagnosis of postmenopausal osteoporosis.

Researchers quantified the comparative effect of csDMARDs on the risk for myocardial infarction and stroke in rheumatoid arthritis.

The safety and efficacy of romosozumab for osteoporosis treatment in postmenopausal women are not significantly affected by reduced kidney function.

Researchers evaluated the long-term safety and tolerability of ixekizumab in adults with psoriasis, psoriatic arthritis and axial spondyloarthritis.

Fracture and mortality risk are not significantly different between periods of ongoing bisphosphonate treatment and bisphosphonate holidays.

Careful consideration should be taken before using hydroxychloroquine in patients with diabetes, particularly in the context of COVID-19.

Researchers evaluated the effect of denosumab on bone mineral density loss in patients with glucocorticoid-induced osteoporosis.

Researchers determined the effects of zoledronic acid on knee cartilage volume loss in knee osteoarthritis and bone marrow lesions.